KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Restructuring Costs (2016 - 2025)

Edwards Lifesciences (EW) has 11 years of Restructuring Costs data on record, last reported at $208.6 million in Q4 2025.

  • For Q4 2025, Restructuring Costs rose 1555.56% year-over-year to $208.6 million; the TTM value through Dec 2025 reached $325.4 million, up 420.64%, while the annual FY2025 figure was $325.4 million, 705.45% up from the prior year.
  • Restructuring Costs reached $208.6 million in Q4 2025 per EW's latest filing, up from $90.4 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $208.6 million in Q4 2025 and bottomed at -$2.4 million in Q3 2022.
  • Average Restructuring Costs over 5 years is $35.4 million, with a median of $10.9 million recorded in 2025.
  • Peak YoY movement for Restructuring Costs: plummeted 151.06% in 2022, then soared 2431.15% in 2023.
  • A 5-year view of Restructuring Costs shows it stood at $7.1 million in 2021, then surged by 602.82% to $49.9 million in 2022, then crashed by 80.16% to $9.9 million in 2023, then grew by 27.27% to $12.6 million in 2024, then skyrocketed by 1555.56% to $208.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Restructuring Costs were $208.6 million in Q4 2025, $90.4 million in Q3 2025, and $15.5 million in Q2 2025.